Product
N,N-Dimethyltryptamine
Aliases
DMT
6 clinical trials
7 indications
Indication
strokeIndication
Healthy Control ParticipantsIndication
Safety IssuesIndication
HealthyIndication
DepressionIndication
Major Depressive DisorderIndication
Major depressive disorderClinical trial
Inhaled N, N-Dimethyltryptamine: a Phase I Study in Healthy AdultsStatus: Completed, Estimated PCD: 2022-11-01
Clinical trial
A Double-blind, Randomised, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety and Pharmacodynamics of Ascending Single and Fixed Repeat Intravenous Doses of DMT in Healthy SubjectsStatus: Active (not recruiting), Estimated PCD: 2024-03-01
Clinical trial
Inhaled N,N-Dimethyltryptamine: a Safety and Tolerability Study in Healthy AdultsStatus: Completed, Estimated PCD: 2023-07-17
Clinical trial
Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects: A Placebo-controlled Cross-over Study (DMT BDR-Study).Status: Not yet recruiting, Estimated PCD: 2024-12-30
Clinical trial
Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over StudyStatus: Completed, Estimated PCD: 2024-03-08
Clinical trial
An Open Label Trial of Inhaled N,N-Dimethyltryptamine in Patients With Partial Response in Depression.Status: Completed, Estimated PCD: 2024-01-15